These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9604055)

  • 21. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
    Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
    Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
    Reid DM; Adami S; Devogelaer JP; Chines AA
    Calcif Tissue Int; 2001 Oct; 69(4):242-7. PubMed ID: 11730260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
    Richy F; Ethgen O; Bruyere O; Reginster JY
    Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.
    Homik JE; Cranney A; Shea B; Tugwell P; Wells G; Adachi JD; Suarez-Almazor ME
    J Rheumatol; 1999 May; 26(5):1148-57. PubMed ID: 10332982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
    Roux C; Oriente P; Laan R; Hughes RA; Ittner J; Goemaere S; Di Munno O; Pouillès JM; Horlait S; Cortet B
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroid effects on proximal femur bone loss.
    Sambrook P; Birmingham J; Kempler S; Kelly P; Eberl S; Pocock N; Yeates M; Eisman J
    J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
    Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoride pharmacokinetics and changes in lumbar spine and hip bone mineral density.
    Patel S; Chan JK; Hosking DJ
    Bone; 1996 Dec; 19(6):651-5. PubMed ID: 8968033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
    Chen W; Johnson KM; FitzGerald JM; Sadatsafavi M; Leslie WD
    Arch Osteoporos; 2018 Oct; 13(1):116. PubMed ID: 30374631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term corticosteroid therapy induces mild changes in trabecular bone texture.
    Lespessailles E; Siroux V; Poupon S; Andriambelosoa N; Pothuaud L; Harba R; Benhamou CL
    J Bone Miner Res; 2000 Apr; 15(4):747-53. PubMed ID: 10780866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.
    Guaydier-Souquières G; Kotzki PO; Sabatier JP; Basse-Cathalinat B; Loeb G
    Osteoporos Int; 1996; 6(2):171-7. PubMed ID: 8704358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
    J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.
    Wallach S; Cohen S; Reid DM; Hughes RA; Hosking DJ; Laan RF; Doherty SM; Maricic M; Rosen C; Brown J; Barton I; Chines AA
    Calcif Tissue Int; 2000 Oct; 67(4):277-85. PubMed ID: 11000340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy.
    Choo R; Lukka H; Cheung P; Corbett T; Briones-Urbina R; Vieth R; Ehrlich L; Kiss A; Danjoux C
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1239-45. PubMed ID: 23265571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
    Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis.
    Rizzoli R; Chevalley T; Slosman DO; Bonjour JP
    Osteoporos Int; 1995 Jan; 5(1):39-46. PubMed ID: 7703623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.